Cardiometabolic Disorders News

Adults with coronary heart disease who followed a Mediterranean diet preserved their kidney function better than those who followed a low-fat diet for 5 years, according to study data published in Clinical Nutrition.

In patients with heterozygous familial hypercholesterolemia already taking maximally tolerated lipid-lowering medication, resmetirom lowered LDL, triglycerides, apolipoprotein B and lipoprotein(a) levels vs. placebo, researchers reported.

The benefit of the SGLT2 inhibitor empagliflozin in patients with HF with preserved ejection fraction did not differ between those who did or did not receive mineralocorticoid receptor antagonists, researchers reported.

The EMPA-Kidney trial will stop early due to evidence of Jardiance’s positive efficacy among patients with chronic kidney disease, according to a press release.

Compared with pre- and postmenopausal women, women in perimenopause had increased fat mass, decreased fat-free mass and greater percent body fat, elevating cardiometabolic risks, according to study results.

Obesity and elevated central adiposity were associated with increased risk for future cancers, including gastrointestinal and gynecologic cancer, researchers reported.

The time of day certain types of foods are eaten may affect risks for cardiovascular disease and all-cause mortality for adults with diabetes, according to study data published in The Journal of Clinical Endocrinology & Metabolism.

Postmenopausal women taking hormone therapy have a duodenal microbiome similar to younger women and a lower abundance of taxaassociated with cardiovascular disease risk compared with those not taking HT, researchers reported.

The link between statin-induced LDL lowering and reduction of CV outcomes may not be as robust as assumed, researchers who conducted a meta-analysis published in JAMA Internal Medicine concluded.

About one third of adults with diabetes has chronic kidney disease, making early detection and treatment of CKD important for improving health outcomes. However, many won’t know they have the disease until it has progressed.